Guideline supports people living with alcohol addiction
December 17, 2019
British Columbians dealing with high-risk drinking or alcohol use disorder will be connected to services that better suit their needs. A new made-in B.C. guideline helps fill a crucial gap in the province’s system of care for people with addictions. The Provincial Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Dis...
BC Centre on Substance Use hosts inaugural Cannabis Science Symposium
November 25, 2019
Dr. M-J Milloy, the Canopy Growth Professor of Cannabis Science at the University of British Columbia (UBC) is proud to bring together patients and other people with lived and living experience with researchers, clinicians, and policymakers for the inaugural Cannabis Science Symposium with the goal of establishing a research agenda for cannabis and...
Cannabis use may reduce likelihood of illicit opioid use for pain management, new research finds
November 19, 2019
For people living with chronic pain, new research from the British Columbia Centre on Substance Use describes how some might be using cannabis to reduce their reliance on illicit opioids. Researchers from the BCCSU and University of British Columbia (UBC) interviewed more than 1,100 people at highest risk of opioid overdose in Vancouver betwee...
Cannabis could help alleviate depression and suicidality among people with PTSD, new study suggests
November 5, 2019
Cannabis may be helping Canadians cope with the effects of post-traumatic stress disorder (PTSD), according to new research from the BC Centre on Substance Use (BCCSU). In an analysis of data collected by Statistics Canada from more than 24,000 Canadians, researchers from the BCCSU and University of British Columbia (UBC) found that having PTSD was...
First-of-its-kind guideline sets out best practices for delivering injectable opioid agonist treatment
September 23, 2019
The first-ever Canadian guidelines for prescribing injectable opioid agonist treatment (iOAT) were released today. The clinical guideline provides optimal strategies for delivering iOAT with prescription heroin and hydromorphone for people with severe opioid use disorder. In 2018, 4,460 Canadians died from an opioid overdose, a 9% increase from 201...
